Search
for
Sort by
Research 61–90 of 1000+
- The relevance of collagen XVII expression in epidermal differentiation and proliferation
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Folliculitis Decalvans-like Alopecia During Treatment With EGFR Inhibitors for Lung Cancer: A Case Series of 6 Patients
- Síndrome PRIDE: una práctica forma de identificar los efectos adversos cutáneos de los inhibidores del EGFR
- 422 Human hair follicles express PD-L1, whose expression is down-regulated by EGFR and MEK inhibitors ex vivo. A potential mechanism for EGFR inhibitor induced sterile folliculitis
- Cutaneous side-effects of EGFR inhibitors and their management.
- Network pharmacology-based preventive effect of XZF on cutaneous toxicities induced by EGFR inhibitor
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Erosive pustular dermatosis of the scalp due to EGFR inhibitors: A multicentric study by EADV task force of ‘Dermatology for Cancer Patients’
- 308 Epidermal keratinocytes regulate bacterial immune responses and host defense through EGFR
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Hair Growth After Gefitinib Treatment
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Drugs and Hair Loss
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Trichoscopic Findings of Erosive Pustular Dermatosis of the Scalp Associated with Gefitinib
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Skin toxicity caused by EGFR antagonists—An autoinflammatory condition triggered by deregulated IL‐1 signaling?
- Dermatologic Reactions to Targeted Therapy
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- “PRIDE” Complex
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- 증례 : Gefitinib에 의해 유발된 반흔성 탈모증
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy